RiTUXimab 1400 mg / hyaluronidase, human recombinant 23,400 UNT in 11.7 mL Injection
RxNorm 1927885
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1927885 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: riTUXimab 1400 mg / hyaluronidase, human recombinant 23,400 UNT in 11.7 mL Injection.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
Semantic Clinical Drug (SCD):
11.7 mL hyaluronidase, human recombinant 2000 UNT/ML / rituximab 120 mg/ML Injection
(Atom ID: 9198001)
Tall Man Lettering Synonym (TMSY):
11.7 mL hyaluronidase, human recombinant 2000 UNT/ML / riTUXimab 120 mg/ML Injection
(Atom ID: 9198967)
Prescribable Name (PSN):
RiTUXimab 1400 mg / hyaluronidase, human recombinant 23,400 UNT in 11.7 mL Injection
(Atom ID: 9198012)
Synonym (SY):
Rituximab 1400 mg / hyaluronidase, human recombinant 23,400 UNT per 11.7 mL Injection
(Atom ID: 9198011)
Tall Man Lettering Synonym (TMSY):
RiTUXimab 1400 mg / hyaluronidase, human recombinant 23,400 UNT per 11.7 mL Injection
(Atom ID: 9198952)
Patient Education
Rituximab and Hyaluronidase Human Injection
Rituximab and hyaluronidase human injection is used alone or with other medications to treat various types of non-Hodgkin's lymphoma (NHL; a type of cancer that begins in a type of white blood cells that normally fights infection). Rituximab and hyaluronidase human injection is also used with other medications to treat chronic lymphocytic leukemia (CLL; a type of cancer of the white blood cells). Rituximab and hyaluronidase human injection is in a class of medications called monoclonal antibodies. It treats the various types of NHL and CLL by killing cancer cells.
[Learn More]
Cancer Chemotherapy
Normally, your cells grow and die in a controlled way. Cancer cells keep growing without control. Chemotherapy is drug therapy for cancer. It works by killing the cancer cells, stopping them from spreading, or slowing their growth. However, it can also harm healthy cells, which causes side effects.
You may have a lot of side effects, some, or none at all. It depends on the type and amount of chemotherapy you get and how your body reacts. Some common side effects are fatigue, nausea, vomiting, pain, and hair loss. There are ways to prevent or control some side effects. Talk with your health care provider about how to manage them. Healthy cells usually recover after chemotherapy is over, so most side effects gradually go away.
Your treatment plan will depend on the cancer type, the chemotherapy drugs used, the treatment goal, and how your body responds. Chemotherapy may be given alone or with other treatments. You may get treatment every day, every week, or every month. You may have breaks between treatments so that your body has a chance to build new healthy cells. You might take the drugs by mouth, in a shot, as a cream, or intravenously (by IV).
NIH: National Cancer Institute
[Learn More]
* Please review the disclaimer below.
